Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Bone health and treatments, Cancer, Lipids, and Metabolism, and Heme Oxygenase-1 and Carbon Monoxide.
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations
Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
The β-Secretase 1 Enzyme as a Novel Therapeutic Target for Prostate Cancer
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment
Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer
FGF-2 is a driving force for chromosomal instability and a stromal factor associated with adverse clinico-pathological features in prostate cancer
Targeting the MYCN–PARP–DNA Damage Response Pathway in Neuroendocrine Prostate Cancer
Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA <i>PCA3</i>
<i>PCAT-1</i> , a Long Noncoding RNA, Regulates BRCA2 and Controls Homologous Recombination in Cancer